Does primary neoadjuvant systemic therapy eradicate minimal residual disease? Analysis of disseminated and circulating tumor cells before and after therapy

BACKGROUND: Patients with breast cancer (BC) undergoing neoadjuvant chemotherapy (NACT) may experience metastatic relapse despite achieving a pathologic complete response. We analyzed patients with BC before and after NACT for disseminated tumor cells (DTCs) in the bone marrow(BM); comprehensively c...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Breast Cancer Res
Autores principales: Kasimir-Bauer, Sabine, Bittner, Ann-Kathrin, König, Lisa, Reiter, Katharina, Keller, Thomas, Kimmig, Rainer, Hoffmann, Oliver
Formato: Artigo
Lenguaje:Inglês
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4751719/
https://ncbi.nlm.nih.gov/pubmed/26868521
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13058-016-0679-3
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares